CGON 8-K 2026-11-06

CG Oncology, Inc. (CGON) 8-K dated 2026-11-06 — accession 0001991792-26-000011.

CG Oncology, Inc. (CGON) is a biotechnology company listed on US.

CGON: CG Oncology Reports Third Quarter 2026 Financial Results and Provides B…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.

Not investment advice. The CGON SEC hub lists recent forms. The stock page is the research view.